NCT05661578 2026-02-09
SKYSCRAPER-11
Hoffmann-La Roche
Phase 2 Completed
Clinical Trials
4 trialsNCT05715281 2025-11-25
Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06331598 2024-12-24
IMperator
Hoffmann-La Roche
Phase 2 Withdrawn
NCT06003621 2024-11-15
MoST-TAP
Omico
Phase 2 Recruiting